<?xml version="1.0" encoding="UTF-8"?>
<xml>
 <records>
  <record>
   <ref-type name="Journal Article">17</ref-type>
   <contributors>
    <authors>
     <author>Kataev, V.A</author>
     <author>Tyurenkov, I.N.</author>
     <author>Meshcheryakova, S.A.</author>
     <author>Perfilova, V.N.</author>
     <author>Munasipova, D.A.</author>
     <author>Borodin, D.D.</author>
    </authors>
   </contributors>
   <titles>
    <title></title>
   </titles>
   <dates>
    <year>2014</year>
    <pub-dates>
     <date>2018-03-14</date>
    </pub-dates>
   </dates>
   <abstract>Oxo- and dioxothietane derivatives of 6-methyl-1-(thietan-3-yl)pyrimidine-2,4-(1H,3H)-dione were synthesized&#13;
by oxidation. N-Alkylation and CH-aminomethylation produced 3-alkyl- and 5-aminomethyl-substituted&#13;
6-methyl-1-(thietan-3-yl)pyrimidine-2,4-(1H,3H)-dione, 6-methyl-1-(1-oxothietan-3-yl)pyrimidine2,4-(1H,3H)-dione,&#13;
and 1-(1,1-dioxothietan-3-yl)-6-methylpyrimidine-2,4-(1H,3H)-dione. The synthesized&#13;
compounds showed hypotensive activity. Compounds causing pronounced, prolonged, and dose-dependent&#13;
hypotensive effects that were comparable with those of reference drugs nebivolol (2 mg/kg), lisinopril&#13;
(10 mg/kg), and amlodipine (1 mg/kg) were discovered.</abstract>
   <urls>
    <web-urls>
     <url>https://repo.bashgmu.ru/publication/727</url>
    </web-urls>
    <pdf-urls>
     <url>https://repo.bashgmu.ru/files/840</url>
    </pdf-urls>
   </urls>
  </record>
 </records>
</xml>
